More on ENTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $2.92 |
|
|||
| Open | $2.99 | ||||
| 52 Wk High | $0.30 | ||||
| 52 Wk Low | $0.10 | ||||
| Day High | $3.03 | ||||
| Day Low | $2.90 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 154,038 | ||||
- Form 424B3 Entera Bio Ltd.
- Correction: Entera to Participate in Upcoming Fall Investor Conferences
- Entera to Participate in Upcoming Fall Investor Conferences
- Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders
- Form S-3 Entera Bio Ltd.
- Form 3 Entera Bio Ltd. For: Aug 18 Filed by: Camisasca Riccardo Paolo
- Form 8-K Entera Bio Ltd. For: Aug 18
- Entera Bio names Riccardo Camisasca as chief medical officer
- Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation
- Form D Entera Bio Ltd.
Entities mentioned with ENTX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Layoffs | View Related Stories »
- Earnings | View Related Stories »
- 13G | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Show More...
